Bicycle Therapeutics Plc
(NASDAQ) BCYC
Bicycle Therapeutics Plc Financials at a Glance
Market Cap
$218.67M
Revenue (TTM)
$63.50M
Net Income (TTM)
-$219.03M
EPS (TTM)
-$3.16
P/E Ratio
-1.38
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$4.37
Volume
8,006
Open
$4.29
Price
$4.37
Volume
8,006
Open
$4.29
Previous Close
$4.37
Daily Range
$4.22 - $4.39
52-Week Range
$3.92 - $9.18
Estimated Earnings Date
Aug 14, 2026
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$4.37
Volume
8,006
Open
$4.29
Previous Close
$4.37
Daily Range
$4.22 - $4.39
52-Week Range
$3.92 - $9.18
Estimated Earnings Date
Aug 14, 2026
BCYC News
Is Bicycle Therapeutics Stock a Buy?
BCYC: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bicycle Therapeutics Plc
Industry
Biotechnology
Sector
Health CareEmployees
288
CEO
Kevin Lee, PhD, MBA
Website
www.bicycletherapeutics.comHeadquarters
Cambridge, CB22 3AT, GB
BCYC Financials
Key Financial Metrics (TTM)
Gross Margin
-11.86%
Operating Margin
-381.75%
Net Income Margin
-344.95%
Return on Equity
-35.74%
Return on Capital
-39.48%
Return on Assets
-33.57%
Earnings Yield
-72.46%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$218.67M
Shares Outstanding
50.27M
Volume
8.01K
Avg. Volume
455.74K
Financials (TTM)
Gross Profit
-$7.53M
Operating Income
-$242.40M
EBITDA
-$211.50M
Operating Cash Flow
-$228.90M
Capital Expenditure
-$106.68K
Free Cash Flow
-$229.01M
Cash & ST Invst.
$559.47M
Total Debt
$15.34M
Bicycle Therapeutics Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$887.00K
-91.1%
Gross Profit
$887.00K
+101.9%
Gross Margin
100.00%
N/A
Market Cap
$218.67M
N/A
Market Cap/Employee
$716.95K
N/A
Employees
305
N/A
Net Income
-$60.83M
-0.1%
EBITDA
-$59.48M
+1.3%
Quarterly Fundamentals
Total Cash
$559.47M
-29.4%
Total Debt
$15.34M
+68.2%
Accounts Receivable
$40.92M
-11.8%
Inventory
$0.00
N/A
Long Term Debt
$13.87M
+307.8%
Short Term Debt
$1.46M
-74.4%
Return on Assets
-33.57%
N/A
Return on Invested Capital
-40.17%
N/A
Free Cash Flow
-$66.64M
+23.7%
Operating Cash Flow
-$65.93M
+24.0%